BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: López-Neyra A, Suárez L, Muñoz M, de Blas A, Ruiz de Valbuena M, Garriga M, Calvo J, Ribes C, Girón Moreno R, Máiz L, González D, Bousoño C, Manzanares J, Pastor Ó, Martínez-Botas J, Del Campo R, Cantón R, Roy G, Menacho M, Arroyo D, Zamora J, Soriano JB, Lamas A. Long-term docosahexaenoic acid (DHA) supplementation in cystic fibrosis patients: a randomized, multi-center, double-blind, placebo-controlled trial. Prostaglandins Leukot Essent Fatty Acids 2020;162:102186. [PMID: 33038833 DOI: 10.1016/j.plefa.2020.102186] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Shrestha N, Mccarron A, Rout-pitt N, Donnelley M, Parsons DW, Hryciw DH. Essential Fatty Acid Deficiency in Cystic Fibrosis Disease Progression: Role of Genotype and Sex. Nutrients 2022;14:4666. [DOI: 10.3390/nu14214666] [Reference Citation Analysis]
2 Borkenhagen B, Prehm P. Recovery of ΔF508-CFTR Function by Citrate. Nutrients 2022;14:4283. [PMID: 36296967 DOI: 10.3390/nu14204283] [Reference Citation Analysis]
3 Strandvik B. Nutrition in Cystic Fibrosis—Some Notes on the Fat Recommendations. Nutrients 2022;14:853. [DOI: 10.3390/nu14040853] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]